CHAD QUIST: Open Payments
NPI 1609836444 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 48 payments from 10 companies in 2025. Trend: 2023 $7,480 · 2024 $8,268 · 2025 $1,256
Food & beverage: $1,169Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $262 |
| LivaNova USA, Inc. | 10 | $212 |
| SK Life Science, Inc. | 4 | $205 |
| Teva Pharmaceuticals USA, Inc. | 5 | $137 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Lundbeck LLC | 3 | $109 |
| JAZZ PHARMACEUTICALS INC. | 3 | $70 |
| Neurelis, Inc. | 2 | $64 |
| UCB, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, UBRELVY, QULIPTA, XCOPRI, Symbravo, VYEPTI, EPIDIOLEX, VALTOCO.
Industry payments across IA — which companies pay providers there.
